ReleaseWire Connect

Global Market Directs pharmaceuticals report, Neuraltus Pharmaceuticals, Inc. - Product Pipeline Review - 2012 provides data on the Neuraltus Pharmaceuticals, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.

TechNavio's analysts forecast the Global High Speed Steel Metal Cutting Tools market to grow at a CAGR of 10.13 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing need to develop superior-quality products. The Global High Speed Steel Metal Cutting Tools market has also been witnessing a reduction in the cost of high speed steel (HSS) metal-cutting tools. However, the increase in preference for carbide metal-cutting tools could pose a challenge to the growth of this market.

TechNavio's analysts forecast the Remanufactured Medical Imaging Devices market in the US to grow at a CAGR of 7.57 percent over the period 2012-2016. One of the key factors contributing to this market growth is the decline of reimbursements for medical imaging procedures. The Remanufactured Medical Imaging Devices market in the US has also been witnessing the trend of eco-friendly and sustainable practices. However, the increased risk of safety and effectiveness could pose a challenge to the growth of this market.

2013 Deep Research Report on Global and Italy PV Inverter Industry was a professional and depth research report on Global and Italy PV Inverter Industry.

Progressively unfolding patient case scenarios were presented to 151 U.S. oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment choices, factors that influence their decisions, barriers to optimal treatment and confidence in treatment and management of patients. This survey was conducted in 2011 and 2012 to compare oncology practice patterns and determine trends across time in the management of advanced prostate cancer. This primary research provides the oncology prescribing information that you are missing, directly from high-prescribing U.S. oncologists on the treatment of patients with advanced prostate cancer.

A survey with unfolding patient case scenarios was presented to 180 U.S. oncologists who manage patients with metastatic breast cancer for their open-ended responses. In each case, oncologists were asked to respond to questions concerning their choices of treatment regimens, factors that influenced their decisions, barriers to optimal patient treatment and confidence in treatment and management of patients. This survey was conducted in 2011 and 2012 to determine trends across time and changes in practice patterns in the management of advanced breast cancer.

The purpose of this study is to examine changes in the market for therapeutics used in the treatment of advanced lung cancer by examining longitudinal practice patterns of oncologists. Progressively unfolding patient case scenarios were presented to 152 U.S. oncologists for their responses to open-ended questions concerning their choices of treatment regimens, factors that influence their decisions, barriers to optimal patient treatment and confidence in treatment and management of patients. This report examines the market for therapeutics by comparing oncology practice patterns in the treatment of advanced lung cancer in 2011 and 2012.

The purpose of this research study is to examine the current and evolving practice patterns of oncologists in managing advanced non-Hodgkins lymphoma. A survey with unfolding patient case scenarios was presented to 158 U.S. oncologists for their open-ended responses to questions concerning their choices of treatment regimens, factors that influenced their decisions, barriers to optimal patient treatment and confidence in treatment and management of patients. This survey was conducted in 2011 and 2012 using parallel cases to determine trends across time and changes in practice patterns in the management of non-Hodgkins lymphoma.

Progressively unfolding patient case scenarios were presented to 200 U.S. oncologists, who manage patients with advanced melanoma, to understand differences in clinical decisions and the factors that influence those decisions. Data presented includes oncologist treatment regimen choices, factors that influence their decisions, barriers to optimal patient care and confidence in patient treatment. This report identifies market changes based on a comparison of physician practice patterns from 2011 and 2012 and provides actionable data for developing marketing strategies.